Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Joshua Isner also recently made the following trade(s):
- On Tuesday, September 10th, Joshua Isner sold 25,811 shares of Axon Enterprise stock. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24.
Axon Enterprise Price Performance
Shares of NASDAQ:AXON traded up $6.11 on Wednesday, reaching $601.29. 850,627 shares of the company traded hands, compared to its average volume of 549,467. The company’s 50 day moving average is $423.98 and its 200-day moving average is $351.79. The stock has a market capitalization of $45.85 billion, a PE ratio of 155.37, a P/E/G ratio of 14.95 and a beta of 0.94. Axon Enterprise, Inc. has a fifty-two week low of $220.51 and a fifty-two week high of $624.84. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Wall Street Analysts Forecast Growth
View Our Latest Report on AXON
Hedge Funds Weigh In On Axon Enterprise
A number of hedge funds have recently modified their holdings of AXON. Brooklyn Investment Group acquired a new position in Axon Enterprise in the third quarter worth about $41,000. Quantbot Technologies LP acquired a new stake in shares of Axon Enterprise during the third quarter worth $84,000. D.A. Davidson & CO. raised its holdings in Axon Enterprise by 0.3% in the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock worth $5,044,000 after purchasing an additional 44 shares during the period. Dai ichi Life Insurance Company Ltd raised its position in shares of Axon Enterprise by 63.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock worth $1,457,000 after purchasing an additional 1,418 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Axon Enterprise by 0.6% during the third quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock worth $17,440,000 after acquiring an additional 276 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- What Are Dividends? Buy the Best Dividend Stocks
- Rocket Lab is the Right Stock for the Right Time
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 3 REITs to Buy and Hold for the Long Term
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.